InnovationRx is your weekly digest of healthcare information. To get it in your inbox, subscribe right here.
The U.S. Division of Veterans Affairs has issued a name for 2 several types of health-related synthetic intelligence instruments on the heels of President Joe Biden’s AI govt order issued this week. That order goals to put guardrails on the use and growth of AI to guard each nationwide safety and society (learn our colleague David Jean’s dispatch from the White Home right here).
The VA’s “tech dash” is concentrated on lowering healthcare employee burnout by providing a mixed $1 million in prizes for corporations competing to construct automated note-taking instruments for docs, in addition to software program that may mix medical information from totally different sources. The U.S. Facilities for Illness Management and Prevention additionally launched a marketing campaign for hospitals to deal with healthcare employee burnout this week.
The VA’s chief AI officer Gil Alterovitz advised Forbes that the company is particularly centered on utilizing know-how to assault administrative burden. A conversation-to-text answer implies that “physicians can truly look you within the eye and have that dialog with you, versus typing on the pc.” The benefit to AI-enabled doc processing means “they do not must manually look by way of a whole lot of various items of paper.”
Alterovitz stated the chosen corporations will work in a “simulated setting” with artificial medical document affected person information so the VA can examine totally different options. “It is a three-month engagement – you may consider it as a bridge towards potential private-public partnerships – that enable us to take a journey collectively,” he stated. Functions shut on January 5, 2024. Extra info right here.
Some Apple Watches Are About To Be Banned In The U.S. What Occurs Subsequent?
A brand new Worldwide Commerce Fee ruling to cease some Apple Watch imports may assist medtech firm Masimo attain a settlement with the $2.7 trillion tech large after a years-long patent battle. It’s an vital bargaining chip for Masimo founder and CEO Joe Kiani, who stated his firm has spent upwards of $65 million associated to ongoing patent and commerce secret litigation with Apple over its pulse oximeter, a blood oxygen sensor that has turn into a promoting level for premium smartwatches and health trackers.
Learn extra right here.
Pipeline & Deal Updates
FDA Approvals: The FDA’s been busy for the previous few days, having issued a number of approvals, together with: Lilly’s first-in-class ulcerative colitis drug Omvoh, Novartis’ Cosentyx for moderate-to-severe instances of the pores and skin situation hidradenitis suppurativa, a 3rd indication for Genetech’s eye remedy Vabysmo and Coherus’ & Junshi Biosciences’ Loqtorzi for nasopharyngeal carcinoma.Duchenne Muscular Dystrophy: The FDA additionally accredited Santhera Prescribed drugs drug Agamree for treating Duchenne Muscular Dystrophy. In the meantime, each Roche and Sarepta Therapeutics noticed their shares tumble after asserting Monday that the part III trial for his or her DMD drug Elevidys failed to achieve its major endpoint, although it did meet a number of secondary endpoints.
Polypeptides: Pittsburgh-based Think about Pharma, which is growing a novel polypeptide drug candidate with probably large therapeutic utility, introduced it has raised a $32.5 million collection A led by IP Traders LLC.
Small Molecules: Gate Bioscience, which is growing small molecules to focus on extracellular proteins, introduced it has emerged from stealth with a $60 million collection A co-led by Versant Ventures and Andreessen Horowitz.
Gene Remedy: AstraZeneca introduced it’s entered right into a collaboration settlement with biotech firm Cellecitis to develop new gene and cell therapies. As a part of the deal, AstraZeneca is initially making a $25 million money fee to Cellecitis and likewise making an $80 million fairness funding. A further second funding of $140 million is anticipated to shut in early 2024, pending approvals, and Cellecitis is moreover eligible for as much as $220 in milestone funds, plus royalties on medicine developed from the collaboration.
Drone Supply: The Cleveland Clinic stated it plans to start out utilizing zones in partnership with Zipline to ship specialty medicines for sufferers in northeast Ohio beginning in 2025. Ultimately the well being system plans to ship lab samples, surgical provides and different objects.
AI: Covera Well being, a startup utilizing AI to enhance the accuracy of radiology imaging, stated it has raised $25 million in dedicated Collection C financing led by Perception Companions, with the opportunity of one other $25 million sooner or later.
Drug Targets: 23andMe has prolonged an information licensing collaboration with GSK for $20 million. The drugmaker will acquire entry to de-identified genetic information to determine new drug targets.
This Startup Raised $30 Million To Take On Microsoft’s AI Notetaker For Medical doctors
The Collection B spherical led by Spark Capital values 5-year outdated Abridge, which is utilized by 5,000 docs, at $200 million. It is up in opposition to Nuance, which Microsoft purchased for $18.8 billion, and whose extra rudimentary dictation software program is utilized by half one million docs. However Nuance solely not too long ago introduced totally automated medical note-taking know-how that doesn’t require a human within the loop to verify for accuracy. In different phrases, the race to dominate the marketplace for AI medical scribes continues to be anybody’s to win.
Learn extra right here.
Different Healthcare Information
CVS Well being reported web earnings of $2.2 billion with revenues rising partially to acquisitions of Oak Avenue Well being and Signify Well being.
GlaxoSmithKline boosted its revenue forecast for the second time this yr amid booming demand for its new RSV vaccine.
Sanofi and AstraZeneca’s RSV immunization for infants known as nirsevimab is in restricted provide, so the CDC has advisable prioritizing doses for top threat infants.
Over one in 5 coronary stents had been pointless, costing Medicare $800 million a yr and placing sufferers liable to issues, a brand new report discovered.
A European Union company stated there isn’t any confirmed hyperlink between weight reduction medicine like Ozempic or Wegovy and thyroid most cancers.
A affected person who acquired the second-ever pig coronary heart transplant died six weeks after the surgical procedure.
Throughout Forbes
A Platform Storing TikTok Company Secrets and techniques Was Inspected By The Chinese language Authorities
How To Revenue From Loopholes In The Environment friendly Market
Hedge Fund Billionaire John Overdeck’s Estranged Spouse Sues Over Motion Of Belief Belongings To Wyoming Earlier than Her Divorce Submitting
What Else We’re Studying
Life science traders shut practically $6 billion in new funds (STAT)
Some deaf youngsters in China can hear after gene remedy (MIT Expertise Assessment)